Brigham and Women’s Hospital has a long history of transforming health care for women, including advancements in fertility treatments. In 1944, researchers were the first to fertilize a human ovum in a test tube (Free Hospital for Women). The Center for Infertility and Reproductive Surgery is continuing this tradition today. Our physicians are pioneering advancements in the treatment of infertility by leading a number of ambitious research programs and clinical trials in the following areas:
- Robotic Surgery
- IVF Translational Program
- Fertility Preservation
- Stem Cell Research
In Vitro Fertilization (IVF) Research Study
Brigham and Women’s Hospital is currently seeking patients for the Thrive-IVF Research Study. The study is evaluating the efficacy, safety, and tolerability of NT100, an investigational medicine in women who have had repeated IVF failures despite having good quality embryos. NT100 is a novel treatment that is being evaluated to determine if it improves the chances of getting pregnant after IVF.
You may be eligible for the Thrive-IVF Research Study if you are between 21and 38 years of age, have had three or more failed IVF cycles that included transfer of good quality embryos (at least two of these involving the transfer of fresh embryos).
Qualified participants will receive study-related tests and procedures at no cost, including study medication and $1000 towards the cost of embryo storage.
If you are interested in learning more about the Thrive-IVF Research Study and whether you may be eligible to participate, please contact Elizabeth Ginsburg, MD, at (617) 732-4285.